1. Effect of hepatic impairment on the pharmacokinetics and pharmacodynamics of a single dose of rivaroxaban, an oral, direct Factor Xa inhibitor. (20th June 2013) Authors: Kubitza, Dagmar; Roth, Angelika; Becka, Michael; Alatrach, Abir; Halabi, Atef; Hinrichsen, Holger; Mueck, Wolfgang Journal: British journal of clinical pharmacology Issue: Volume 76:Number 1(2013:Jul.) Page Start: 89 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Effect of Renal Function Impairment on the Pharmacokinetics, Safety, and Tolerability of the Iminosugar Sinbaglustat. (15th January 2021) Authors: Melchior, Meggane; Dingemanse, Jasper; Alatrach, Abir; Feldkamp, Thorsten; Sidharta, Patricia N.; Géhin, Martine Journal: Journal of clinical pharmacology Issue: Volume 61:Number 7(2021) Page Start: 932 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗